186 related articles for article (PubMed ID: 37892420)
1. Effect of Oleoylethanolamide-Based Dietary Supplement on Systemic Inflammation in the Development of Alimentary-Induced Obesity in Mice.
Ivashkevich D; Ponomarenko A; Manzhulo I; Sultanov R; Dyuizen I
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892420
[TBL] [Abstract][Full Text] [Related]
2. Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial.
Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Roshanravan N; Shakeri-Bavil A; Asghari-Jafarabadi M; Farrin N; Mobasseri M
J Cell Physiol; 2021 Jan; 236(1):417-426. PubMed ID: 32572955
[TBL] [Abstract][Full Text] [Related]
3. Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.
Igarashi M; DiPatrizio NV; Narayanaswami V; Piomelli D
Biochim Biophys Acta; 2015 Sep; 1851(9):1218-26. PubMed ID: 26024927
[TBL] [Abstract][Full Text] [Related]
4. Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma.
Kwon EK; Choi Y; Yoon IH; Won HK; Sim S; Lee HR; Kim HS; Ye YM; Shin YS; Park HS; Ban GY
Exp Mol Med; 2021 Jun; 53(6):1036-1045. PubMed ID: 34079051
[TBL] [Abstract][Full Text] [Related]
5. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
[TBL] [Abstract][Full Text] [Related]
6. Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity.
Tovar R; Gavito AL; Vargas A; Soverchia L; Hernandez-Folgado L; Jagerovic N; Baixeras E; Ciccocioppo R; Rodríguez de Fonseca F; Decara J
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444748
[TBL] [Abstract][Full Text] [Related]
7. Oleoylethanolamide alleviates macrophage formation via AMPK/PPARα/STAT3 pathway.
Zhao Y; Yan L; Peng L; Huang X; Zhang G; Chen B; Ren J; Zhou Y; Yang L; Peng L; Jin X; Wang Y
Pharmacol Rep; 2018 Dec; 70(6):1185-1194. PubMed ID: 30336422
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory Effect of Polyunsaturated Fatty Acid N-Acylethanolamines Mediated by Macrophage Activity In Vitro and In Vivo.
Egoraeva A; Tyrtyshnaia A; Ponomarenko A; Ivashkevich D; Sultanov R; Manzhulo I
Inflammation; 2023 Dec; 46(6):2306-2319. PubMed ID: 37490220
[TBL] [Abstract][Full Text] [Related]
9. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.
Thabuis C; Destaillats F; Landrier JF; Tissot-Favre D; Martin JC
J Nutr Biochem; 2010 Oct; 21(10):922-8. PubMed ID: 19954948
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
Tutunchi H; Saghafi-Asl M; Ostadrahimi A
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
[TBL] [Abstract][Full Text] [Related]
12. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats.
Sayd A; Antón M; Alén F; Caso JR; Pavón J; Leza JC; Rodríguez de Fonseca F; García-Bueno B; Orio L
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548106
[TBL] [Abstract][Full Text] [Related]
14. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial.
Payahoo L; Khajebishak Y; Alivand MR; Soleimanzade H; Alipour S; Barzegari A; Ostadrahimi A
Appetite; 2019 Oct; 141():104301. PubMed ID: 31132422
[TBL] [Abstract][Full Text] [Related]
15. Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.
Thabuis C; Destaillats F; Lambert DM; Muccioli GG; Maillot M; Harach T; Tissot-Favre D; Martin JC
J Lipid Res; 2011 Jul; 52(7):1373-82. PubMed ID: 21515921
[TBL] [Abstract][Full Text] [Related]
16. Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration.
Antón M; Alén F; Gómez de Heras R; Serrano A; Pavón FJ; Leza JC; García-Bueno B; Rodríguez de Fonseca F; Orio L
Addict Biol; 2017 May; 22(3):724-741. PubMed ID: 26857094
[TBL] [Abstract][Full Text] [Related]
17. Oleoylethanolamide attenuates the stress-mediated potentiation of rewarding properties of cocaine associated with an increased TLR4 proinflammatory response.
González-Portilla M; Moya M; Montagud-Romero S; de Fonseca FR; Orio L; Rodríguez-Arias M
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jun; 124():110722. PubMed ID: 36724838
[TBL] [Abstract][Full Text] [Related]
18. Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study.
Stensson N; Ghafouri B; Gerdle B; Ghafouri N
Lipids Health Dis; 2017 Jun; 16(1):112. PubMed ID: 28606089
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of oleoylethanolamide (OEA) on H₂O₂-induced human umbilical vein endothelial cell (HUVEC) injury and apolipoprotein E knockout (ApoE-/-) atherosclerotic mice.
Ma L; Guo X; Chen W
Int J Clin Exp Pathol; 2015; 8(6):6301-11. PubMed ID: 26261506
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1/AMPK activation.
Yao E; Zhang G; Huang J; Yang X; Peng L; Huang X; Luo X; Ren J; Huang R; Yang L; Zhou Y; Zhuo R; Zhao Y; Jin X
J Cell Physiol; 2019 Aug; 234(10):18392-18407. PubMed ID: 30895621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
